Early Pathogenic Steps in Xenobiotic-Induced Autoimmunity
外源性自身免疫的早期致病步骤
基本信息
- 批准号:10579269
- 负责人:
- 金额:$ 52.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-24 至 2026-11-30
- 项目状态:未结题
- 来源:
- 关键词:AffectAnimal ModelAntibody FormationAntigen ReceptorsAppearanceAutoantibodiesAutoantigensAutoimmuneAutoimmune DiseasesAutoimmune ResponsesAutoimmunityB cell repertoireB-Cell Antigen ReceptorB-LymphocytesBiological ModelsBloodBone MarrowCD4 Positive T LymphocytesCharacteristicsChronicDBA/2 MouseDevelopmentDiagnosisDiseaseEarly identificationEpitopesEventExcisionExperimental Animal ModelExposure toGenesGeneticHumanHypertrophyImmune ToleranceImmune responseImmunologicsInflammationInflammatory ResponseInterferon Type IIInterleukin-6KidneyKnowledgeLinkLymphoidMercuric chlorideMercuryModelingMolecularMusNatural ImmunityNuclear AntigensNucleic AcidsNucleolar ProteinsOutcomePathogenicityPathologicPathologyPatientsPatternPeptide Initiation FactorsProductionRNAResistanceSclerodermaSerologySeverity of illnessSilicon DioxideSiteSpleenSterilityStructure of germinal center of lymph nodeStudy modelsSystemic Lupus ErythematosusT-LymphocyteTissuesXenobioticsadaptive immunityautoreactive B cellclinical diagnosisdraining lymph nodeexperimental studyfibrillaringenetic elementhuman diseasehuman modelinflammatory markerinsightresponsesecondary lymphoid organsubcutaneoussystemic autoimmune diseaseurinary
项目摘要
Autoimmunity is thought to result from a combination of genetics, environmental triggers, and stochastic events.
A characteristic of systemic autoimmune diseases, like systemic lupus erythematosus (SLE), are autoantibodies
against nuclear antigens (ANA), however the events that initiate such autoantibody responses remain poorly
understood. This is due largely to an incomplete understanding of when and how autoimmunity begins in humans
and animals models of spontaneous autoimmunity. However, certain environmental/xenobiotic exposures have
been linked to autoimmunity in humans and reproduced in experimental animal models, thus providing model
systems where the initiating event and its exposure site are known. These induced models of autoimmunity
provide a unique opportunity for dissecting the immunological response specific to known inciting agents and
are significantly more amenable to identifying the early events necessary for autoimmunity that are difficult to
study in spontaneous autoimmune diseases. We propose to exploit this feature in order to study the early
molecular and cellular events leading to loss of B cell tolerance and autoantibody production. Mercury exposure
in humans is linked with pathological outcomes including inflammatory markers, autoantibodies and renal
pathology. These observation have been faithfully reproduced in experimental animal models. Importantly,
murine mercury-induced autoimmunity (mHgIA) induces an MHC-restricted autoantibody response against the
nucleolar protein fibrillarin which is also found in patients with SLE and Scleroderma. We believe that elucidation
of the mercury-induced anti-fibrillarin response will provide insight into the early events necessary for the creation
and expansion of autoreactive B cells, a cardinal feature of the autoimmune response. We propose three aims
that will define different, but related, events in the secondary lymphoid organs that result in loss of tolerance and
autoantibody production following mercury exposure. Aim 1 will define the early immunological steps in
xenobiotic-induced autoimmunity, and characterize the immunopathologic changes in the draining lymph nodes
(LNs), spleen and bone marrow following single and multiple subcutaneous exposures to mercury. In Aim 2 we
will determine what factors are critical for the development of activated CD4 T cells, autoimmune GCs, and
autoAbs in the early stages of mHgIA. Proposed experiments will determine how the deficiencies of several key
genes required for T-dependent immune responses in SLE or mHgIA (Unc93b1, Tlr7, Il6, and Ifng) affect the
early and autoimmune secondary lymphoid organ responses to HgCl2. Finally, Aim 3 studies will determine the
Hg-induced autoreactive B cell repertoire by characterizing the evolving B cell antigen receptor repertoire
induced by mercury exposure in secondary lymphoid organs. When completed these studies will lead to a greater
understanding of the early molecular and cellular events leading to development of autoantibody production.
自身免疫被认为是遗传、环境触发和随机事件共同作用的结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kenneth Michael Pollard其他文献
Kenneth Michael Pollard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kenneth Michael Pollard', 18)}}的其他基金
Collaborative Cross Strains as Models of Systemic Autoimmunity
协作交叉菌株作为系统性自身免疫模型
- 批准号:
10730346 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
Early Pathogenic Steps in Xenobiotic-Induced Autoimmunity
外源性自身免疫的早期致病步骤
- 批准号:
10367852 - 财政年份:2022
- 资助金额:
$ 52.36万 - 项目类别:
Modeling xenobiotic-induced autoimmunity using Collaborative Cross strains.
使用协作交叉菌株模拟外源性诱导的自身免疫。
- 批准号:
9912022 - 财政年份:2020
- 资助金额:
$ 52.36万 - 项目类别:
Do Xenobiotics Exacerbate Idiopathic Autoimmunity?
异生素会加剧特发性自身免疫吗?
- 批准号:
9506204 - 财政年份:2018
- 资助金额:
$ 52.36万 - 项目类别:
The effect of age on xenobiotic-induced autoimmunity
年龄对异生素诱导的自身免疫的影响
- 批准号:
10002226 - 财政年份:2018
- 资助金额:
$ 52.36万 - 项目类别:
Do Xenobiotics Exacerbate Idiopathic Autoimmunity?
异生素会加剧特发性自身免疫吗?
- 批准号:
9762107 - 财政年份:2018
- 资助金额:
$ 52.36万 - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
$ 52.36万 - 项目类别:
Grant-in-Aid for Early-Career Scientists